Understanding the Current Regulations Underpinning Clinical Trials Harnessing CDx Tests for Clearer Guidelines on the Tests

Time: 1:50 pm
day: Day 2 Track C PM


  • Providing clarification on the regulatory status of CDx assays in clinical trials
  • Shifting attention to the regulations pertaining tests run in clinical trials – why is it important
  • What are some approaches used for biomarker testing in clinical trials and how do they pave the way for market access